In the univariate analysis of clinical factors associated with ORR in patients with AM, we observed no significant associations with BRAF mutation status, brain metastasis, sex, LDH level, liver metastasis, ethnicity, prior immunotherapy, or number of metastases (Supplementary Table S1). This evidence concerns the gene BRAF and acute myeloblastic leukemia with maturation.